OBJECTIVE: To determine the magnitude and importance of declines in model performance associated with altering the data source and time frame from which comorbid conditions were identified in claims-based risk adjustment among persons with hip fracture. STUDY DESIGN AND SETTING: Medicare claims data were used to identify incident hip fracture cases in 1999. Three risk-adjustment instruments were evaluated: one by Iezzoni, the Charlson Index (Romano adaptation), and the Clinical Classification Software (CCS). Several implementation strategies, defined by altering data source (MedPar and/or Part B claims) and time frame (index hospitalization and/or 1-year preperiod), were assessed for each instrument. Logistic regression was used to predict 1-year mortality, and model performance was compared. RESULTS: Each instrument had modest ability to predict 1-year mortality after hip fracture. The CCS performed best overall (c=0.76), followed by the Iezzoni (c=0.73) and Charlson models (c=0.72). Although each instrument performed most favorably when applied to both inpatient and outpatient claims and when comorbidities were considered during the preperiod, varying data source and time frame had trivial effects on model performance. CONCLUSION: The similar predictive ability of the three risk-adjustment instruments suggests that ease of implementation be a key consideration in choosing an approach for hip fracture populations.
OBJECTIVE: To determine the magnitude and importance of declines in model performance associated with altering the data source and time frame from which comorbid conditions were identified in claims-based risk adjustment among persons with hip fracture. STUDY DESIGN AND SETTING: Medicare claims data were used to identify incident hip fracture cases in 1999. Three risk-adjustment instruments were evaluated: one by Iezzoni, the Charlson Index (Romano adaptation), and the Clinical Classification Software (CCS). Several implementation strategies, defined by altering data source (MedPar and/or Part B claims) and time frame (index hospitalization and/or 1-year preperiod), were assessed for each instrument. Logistic regression was used to predict 1-year mortality, and model performance was compared. RESULTS: Each instrument had modest ability to predict 1-year mortality after hip fracture. The CCS performed best overall (c=0.76), followed by the Iezzoni (c=0.73) and Charlson models (c=0.72). Although each instrument performed most favorably when applied to both inpatient and outpatient claims and when comorbidities were considered during the preperiod, varying data source and time frame had trivial effects on model performance. CONCLUSION: The similar predictive ability of the three risk-adjustment instruments suggests that ease of implementation be a key consideration in choosing an approach for hip fracture populations.
Authors: Michael Pine; Harmon S Jordan; Anne Elixhauser; Donald E Fry; David C Hoaglin; Barbara Jones; Roger Meimban; David Warner; Junius Gonzales Journal: JAMA Date: 2007-01-03 Impact factor: 56.272
Authors: Anthony J Perkins; Kurt Kroenke; Jürgen Unützer; Wayne Katon; John W Williams; Carol Hope; Christopher M Callahan Journal: J Clin Epidemiol Date: 2004-10 Impact factor: 6.437
Authors: Eric J Lenze; Michael C Munin; Elizabeth R Skidmore; Mary Amanda Dew; Joan C Rogers; Ellen M Whyte; Tanya Quear; Amy Begley; Charles F Reynolds Journal: J Am Geriatr Soc Date: 2007-01 Impact factor: 5.562
Authors: J P W Bynum; J-E Bell; R V Cantu; Q Wang; C M McDonough; D Carmichael; T D Tosteson; A N A Tosteson Journal: Osteoporos Int Date: 2016-02-24 Impact factor: 4.507
Authors: J C Munson; J P W Bynum; J-E Bell; C McDonough; Q Wang; T Tosteson; A N A Tosteson Journal: Osteoporos Int Date: 2018-09-19 Impact factor: 4.507
Authors: L Joseph Melton; Elizabeth J Atkinson; Jennifer L St Sauver; Sara J Achenbach; Terry M Therneau; Walter A Rocca; Shreyasee Amin Journal: J Bone Miner Res Date: 2014-07 Impact factor: 6.741
Authors: Benjamin S Brooke; Philip P Goodney; Larry W Kraiss; Daniel J Gottlieb; Matthew H Samore; Samuel R G Finlayson Journal: Lancet Date: 2015-06-17 Impact factor: 79.321